stars 1 stars 2 stars 3

Nucleonics, founded in January 2001, is an emerging biotechnology company focused on the development of novel RNA interference-based therapeutics for viral and other diseases. The company believes its proprietary technology and delivery systems for expressed interfering RNA offers advantages over other RNAi approaches in terms of safety and efficacy that will enable Nucleonics to become a leader in this emerging field. The privately owned company is headquartered in Malvern, Pa. Contact: Nucleonics, Inc.

Nucleonics , Inc. Questions

The Nucleonics , Inc. annual revenue was $9.6 million in 2026.

Nucleonics , Inc. is based in Horsham, Pennsylvania.

The NAICS codes for Nucleonics , Inc. are [44, 325, 3254, 32, 445, 32541].

The SIC codes for Nucleonics , Inc. are [549, 2834, 54, 283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users